These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 1967142
1. Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration. Zaczek R, Culp S, De Souza EB. J Neurochem; 1990 Jan; 54(1):195-204. PubMed ID: 1967142 [Abstract] [Full Text] [Related]
2. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD, Nichols DE, Yim GK. Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126 [Abstract] [Full Text] [Related]
3. Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration. Zaczek R, Culp S, Goldberg H, Mccann DJ, De Souza EB. J Pharmacol Exp Ther; 1991 May 15; 257(2):820-9. PubMed ID: 1903445 [Abstract] [Full Text] [Related]
4. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine. Zaczek R, Hurt S, Culp S, De Souza EB. NIDA Res Monogr; 1989 May 15; 94():223-39. PubMed ID: 2575226 [Abstract] [Full Text] [Related]
5. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. Zaczek R, Culp S, De Souza EB. J Pharmacol Exp Ther; 1991 May 15; 257(2):830-5. PubMed ID: 1903446 [Abstract] [Full Text] [Related]
6. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations. Schäfer R, Reiser G. Br J Pharmacol; 1997 Jul 15; 121(5):913-22. PubMed ID: 9222547 [Abstract] [Full Text] [Related]
7. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. McKenna DJ, Guan XM, Shulgin AT. Pharmacol Biochem Behav; 1991 Mar 15; 38(3):505-12. PubMed ID: 1829838 [Abstract] [Full Text] [Related]
8. Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes. Brady JF, Di Stefano EW, Cho AK. Life Sci; 1986 Oct 20; 39(16):1457-64. PubMed ID: 2877380 [Abstract] [Full Text] [Related]
9. [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paper. Wang SS, Ricaurte GA, Peroutka SJ. Eur J Pharmacol; 1987 Jun 26; 138(3):439-43. PubMed ID: 2887443 [Abstract] [Full Text] [Related]
10. Characteristics of [3H](+)-amphetamine binding sites in the rat central nervous system. Hauger RL, Hulihan-Giblin B, Skolnick P, Paul SM. Life Sci; 1984 Feb 20; 34(8):771-82. PubMed ID: 6700378 [Abstract] [Full Text] [Related]
11. 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Lyon RA, Glennon RA, Titeler M. Psychopharmacology (Berl); 1986 Feb 20; 88(4):525-6. PubMed ID: 2871581 [Abstract] [Full Text] [Related]
14. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Hekmatpanah CR, Peroutka SJ. Eur J Pharmacol; 1990 Feb 20; 177(1-2):95-8. PubMed ID: 1971219 [Abstract] [Full Text] [Related]
15. Evidence for specific methylenedioxymethamphetamine (ecstasy) binding sites in the rat brain. Gehlert DR, Schmidt CJ, Wu L, Lovenberg W. Eur J Pharmacol; 1985 Dec 10; 119(1-2):135-6. PubMed ID: 2867919 [No Abstract] [Full Text] [Related]
19. Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes. Rinken A, Harro J, Engström L, Oreland L. Biochem Pharmacol; 1998 Feb 15; 55(4):423-31. PubMed ID: 9514076 [Abstract] [Full Text] [Related]